110821 ⎘
ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus A, i.e. influenza A virus Methods of production or purification of viral material
Sub-classes:RATIONALLY DESIGNED SINGLE-ROUND INFECTIOUS VIRUS AND METHODS OF USE THEREOF
#2METHOD FOR VIRUS CAPTURE
#3RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED NA
#4VIRUS-LIKE PARTICLE STABLY EXPRESSED BY ANIMAL CELLS AS VACCINE ANTIGEN AGAINST COVID-19 AND INFLUENZA VIRUS
#5INFLUENZA VIRUS MUTANTS AND USES THEREFOR
#6PRODUCTION OF VIRUSES IN CELL CULTURE
#7COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION
#8Novel Adjuvant Compositions
#9COMPOSITIONS AND METHODS FOR ENHANCING PRODUCTION, GROWTH, SPREAD, OR ONCOLYTIC AND IMMUNOTHERAPEUTIC EFFICACY OF INTERFERON-SENSITIVE VIRUSES
#10RNA-ONLY DERIVED ORTHOMYXOVIRUSES AND ASSOCIATED VECTORS AND USES THEREOF
#11HOST FACTORS THAT ENHANCE VIRAL PRODUCTION VIA VIRALLY DRIVEN FITNESS-BASED CRISPR SCREENING
#12INFLUENZA VIRUS REPLICATION FOR VACCINE DEVELOPMENT
#13RESPIRATORY VIRUS COMBINATION VACCINES
#14ENGINEERED INFLUENZA VIRUSES EXPRESSING SARS-COV-2 ANTIGENS, VACCINES AND METHODS OF MAKING AND USING THE SAME
#15METHOD FOR SEPARATING AND PURIFYING INFLUENZA VIRUS-LIKE PARTICLES (VLPS) USING AQUEOUS TWO-PHASE SYSTEM (ATPS)
#16LIMITING VIRAL INFECTION AND REPLICATION IN STEM CELLS
#17DOWNSTREAM PROCESS FOR PURIFICATION OF VIRAL PROTEINS WITH HYDROPHOBIC MEMBRANE DOMAIN FOR USE IN VACCINE COMPOSITIONS
#18RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED NA
#19TRAIT SELECTION IN AVIANS
#20INFLUENZA VIRUSES WITH MUTANT PB2 GENE SEGMENT AS LIVE ATTENUATED VACCINES
#21INFLUENZA VIRUS PRODUCTION METHOD USING SINGLE-USE CULTURE PROCESS SYSTEM AND RAPID CONFIRMATION TEST OF INFLUENZA VIRUS ANTIGEN PURIFICATION CONDITION
#22INFLUENZA VIRUS SURFACE PROTEIN-DERIVED RECOMBINANT HEMAGGLUTININ PROTEIN FORMING TRIMER, AND USE THEREOF
#23Influenza virus mutants and uses therefor
#24Vaccine compositions having improved stability and immunogenicity
#25Whole avian-origin reverse genetic system and its use in producing H7N9 subtype avian influenza vaccine
#26INFLUENZA HEMAGGLUTININ PROTEINS AND METHODS OF USE THEREOF
#27CHROMATOGRAPHY MEDIUM
#28Compositions and methods for viral sensitization
#29DRUG-RESISTANT INFLUENZA VIRUS STRAINS
#30INFLUENZA VIRUS-LIKE PARTICLE PRODUCTION IN PLANTS
#31Recombinant influenza viruses and constructs and uses thereof
#32PRODUCTION OF VIRUSES IN CONTINUOUSLY GROWING EPITHELIAL CELL LINES DERIVED FROM CHICKEN GUT
#33Production of viruses in cell culture
#34Materials and methods for respiratory disease control in canines
#35METHOD
#36Adjuvant compositions
#37Reassortant influenza virus production method
#38Recombinant influenza viruses with stabilized NA
#39METHOD FOR GRADUAL CONSTRUCTION OF REASSORTANT INFLUENZA VIRUS
#40Fabric top for a convertible vehicle and convertible vehicle
#41MDCK suspension cell lines in serum-free, chemically-defined media for vaccine production
#42Tim protein-bound carrier, methods for obtaining, removing and detecting extracellular membrane vesicles and viruses using said carrier, and kit including said carrier
#43Cell-derived viral vaccines with low levels of residual cell DNA
#44Compositions and methods for viral sensitization
#45H9 avian influenza vaccine strain which differentiates infected from vaccinated animals, and preparation method therefor
#46Compositions and methods for enhancing production, growth, spread, or oncolytic and immunotherapeutic efficacy of interferon-sensitive viruses
#47Influenza viruses with mutant PB2 gene segment as live attenuated vaccines
#48Generation of infectious influenza viruses from virus-like particles
#49Influenza virus-like particle production in plants
#50INFLUENZA VIRUS REASSORTMENT
#51Vaccine compositions
#52Transkingdom platform for therapeutic nucleic acid delivery
#53Chromatography medium
#54Vaccine compositions having improved stability and immunogenicity
#55TRAIT SELECTION IN AVIANS
#56Influenza virus mutants and uses therefor
#57Compositions and methods to increase production
#58GENERIC ASSAYS FOR DETECTION OF INFLUENZA VIRUSES
#59METHOD FOR PURIFYING VIRUS
#60Production of viruses in cell culture
#61Materials and methods for respiratory disease control in canines
#62Porcine cell line for virus production
#63Production of viruses in avian eggs
#64Recombinant influenza virus-like particles (VLPS) produced in transgenic plants
#65Marker system, in particular for baculovirus-expressed subunit antigens
#66Influenza vaccines
#67Concentration device suitable for dielectrophoresis and method for concentrating particles with the same
#68Method of long-term preservation of chemical and biological species using sugar glasses
#69Method for the separation of virus compositions including depletion and purification thereof
#70Removal of residual cell culture impurities
#71Methods and materials for microorganism capture
#72Highly efficient influenza matrix (M1) proteins
#73Influenza virus mutants and uses therefor
#74Influenza virus vector for virotherapy
#75Influenza virus replication for vaccine development
#76Adjuvant compositions
#77Genetically engineered swine influenza virus and uses thereof
#78Inactivation of viruses by delipidation
#79Production of viruses in avian eggs
#80Production of viruses in cell culture
#81Oil-in-water emulsion influenza vaccine
#82Method for the production of stabile vaccines
#83MDCK suspension cell lines in serum-free, chemically-defined media for vaccine production
#84SAMPLE QUANTIFICATION BY DISC CENTRIFUGATION
#85METHOD FOR PRODUCING CONTINUOUS CELL LINES
#86Recombinant Influenza Viruses for Vaccines and Gene Therapy
#87Influenza hemagglutinin proteins and methods of use thereof
#88Bird flu vaccine combination comprising virus-like particles and novel adjuvants
#89Compositions and methods for enhancing virus replication
#90Reverse genetics systems
#91Attenuated influenza vaccines and uses thereof
#92Materials and methods for respiratory disease control in canines
#93Vaccine compositions having improved stability and immunogenicity
#94Tim protein-bound carrier, methods for obtaining, removing and detecting extracellular membrane vesicles and viruses using said carrier, and kit including said carrier
#95Compositions and methods for viral sensitization
#96Plasmids and method for obtaining viral particles
#97FORMULATION OF SUGAR SOLUTIONS FOR CONTINUOUS ULTRACENTRIFUGATION FOR VIRUS PURIFICATION
#98Method for preparing a vaccine antigen, resulting vaccine antigen and uses
#99RECOMBINANT H7 HEMAGGLUTININ AND USE THEREOF
#100Influenza virus reassortment
#101Adjuvant compositions
#102Highly efficient influenza matrix (M1) proteins
#103Oil-in-water emulsion influenza vaccine
#104Live attenuated viral vaccine created by self-attenuation with species-specific artificial MicroRNA
#105Vaccine compositions having improved stability and immunogenicity
#106Process for producing influenza vaccine
#107Influenza virus hemagglutinin protein as a vaccine antigen
#108CELL FREE TRANSLATION SYSTEM FOR COMPOUND SCREENING AND RELATED USES
#109Recombinant swine influenza virus and uses thereof
#110Influenza virus reassortment
#111Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin
#112INFLUENZA HEMAGGLUTININ PROTEINS AND METHODS OF USE THEREOF
#113Method for endotoxin removal
#114Influenza virus replication for vaccine development
#115Generation of infectious influenza viruses from virus-like particles
#116Chromatography medium
#117Chimeric viruses presenting non-native surface proteins and uses thereof
#118Influenza virus vaccines and uses thereof
#119Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
#120Methods for producing virus particles with simplified glycosylation of surface proteins
#121Cell strain having increased virus production ability and production method therefor
#122Excipients for stabilising viral particles, polypeptides or biological material
#123Hybrid influenza seed viruses, compositions thereof, and use thereof in the diagnosis or therapy of influenza
#124REMOVAL OF RESIDUAL CELL CULTURE IMPURITIES
#125GENERIC ASSAYS FOR DETECTION OF INFLUENZA VIRUSES
#126Influenza virus vector for virotherapy
#127Marker system, in particular for baculovirus-expressed subunit antigens
#128Sulfated cellulose hydrate membrane, method for producing same, and use of the membrane as an adsorption membrane for a virus purification process
#129Process for stabilizing an adjuvant containing vaccine composition
#130Influenza virus mutants and uses therefor
#131Influenza virus mutants and uses therefor
#132Method for preventing the unfolding of a (poly)peptide and/or inducing the (re-)folding of a (poly)peptide
#133High titer recombinant influenza viruses for vaccines
#134Method of viral purification
#135Method for preparing virosomes
#136Adjuvant compositions and methods of use
#137Recombinant influenza viruses for vaccines and gene therapy
#138Influenza virus vaccines and uses thereof
#139Attenuated influenza vaccines and uses thereof
#140Compositions and methods for enhancing virus replication
#141Preparation method of chromatography medium
#142Method for preparing virosomes
#143Influenza virus-like particle production in plants
#144Influenza virus reassortment
#145MDCK-derived cell strain suspension-cultured in protein-free medium and method for proliferating virus using cell strain
#146THERMOSENSITIVE MUTANTS OF INFLUENZA VIRUSES
#147Formulation of sugar solutions for continuous ultracentrifugation for virus purification
#148METHODS OF PRODUCING INFLUENZA VACCINE COMPOSITIONS
#149Methods and materials for microorganism capture
#150Influenza virus reassortment
#151Method of replicating viruses in suspension cultures of dog kidney cells
#152Influenza virus reassortment
#153Influenza viruses with mutant PB2 segment as live attenuated vaccines
#154Highly efficient influenza matrix (M1) proteins
#155Production of viral vaccines in suspension on avian embryonic derived stem cell lines
#156Genetically engineered swine influenza virus and uses thereof
#157MDCK-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells
#158Multiprotein assemblies
#159Increasing protein yield in plants
#160Production of infectious influenza viruses
#161Deglycosylated hemagglutinin and manufacture thereof
#162Recombinant influenza vectors with tandem transcription units
#163Influenza virus reassortment method
#164Virus-like particles comprising a matrix protein from a plant enveloped virus and uses thereof
#165Method for producing continuous cell lines
#166Materials and methods for respiratory disease control in canines
#167Influenza hemagglutinin proteins and methods of use thereof
#168Method for endotoxin removal
#169Exogenous internal positive control
#170Influenza virus vaccines and uses thereof
#171Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#172Reassortant influenza viruses for vaccines
#173Recombinant influenza viruses and constructs and uses thereof
#174Process for stabilizing an adjuvant containing vaccine composition
#175Stabilisation method for viruses or bacteria
#176Batches of recombinant adenovirus with altered terminal ends
#177Adjuvant compositions
#178Pol I promoter derived from Vero cells and recombinant vector containing same
#179Methods for producing virus particles with simplified glycosylation of surface proteins
#180Method for improving the production of influenza viruses and vaccine seeds
#181Multi plasmid system for the production of influenza virus
#182Methods of producing influenza vaccine compositions
#183Adjuvant compositions and methods of use
#184METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION
#185Modified viral strains and method for improving the production of vaccine seeds of influenza virus
#186Swine influenza hemagglutinin variants
#187CELL FREE TRANSLATION SYSTEM FOR COMPOUND SCREENING AND RELATED USES
#188MDCK cell lines supporting viral growth to high titers and bioreactor process using the same
#189Highly efficient influenza matrix (M1) proteins
#190Reverse genetics methods for virus rescue
#191Genetically engineered swine influenza virus and uses thereof
#192METHODS FOR STABILIZING INFLUENZA ANTIGEN ENVELOPED VIRUS-BASED VIRUS-LIKE PARTICLE SOLUTIONS
#193Methods and compositions to modulate antiviral and immune activity responses
#194Pathogen restriction factors
#195FED-BATCH PROCESS USING CONCENTRATED CELL CULTURE MEDIUM FOR THE EFFICIENT PRODUCTION OF BIOLOGICS IN EB66 CELLS
#196MULTIPROTEIN ASSEMBLIES
#197METHOD FOR THE PREPARATION OF AN INFLUENZA VIRUS
#198Refrigerator-temperature stable influenza vaccine compositions
#199Reverse genetics systems
#200Methods for isolating and quantifying antigen from vaccines
#201Methods for cultivating cells, propagating and purifying viruses
#202Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#203Swine influenza hemagglutinin variants
#204Production of viral vaccines in suspension on avian embryonic derived stem cell lines
#205ASSAYS FOR INFLUENZA VIRUS HEMAGGLUTININS
#206Process for producing influenza vaccine
#207PROCESS FOR PREPARING AN INFLUENZA SEED VIRUS FOR VACCINE MANUFACTURE
#208GENERIC ASSAY FOR DETECTION OF INFLUENZA VIRUSES
#209Multi plasmids system for the production of influenza virus
#210Recombinant influenza viruses for vaccines and gene therapy
#211Influenza virus vaccine composition and methods of use
#212Chimeric viruses presenting non-native surface proteins and uses thereof
#213Non-tumorigenic MDCK cell line for propagating viruses
#214Oral vaccine fast-dissolving dosage form using starch
#215Separation Of Virus And/Or Protein From Nucleic Acids By Primary Amines
#216METHOD FOR PRODUCING VIRUS FROM CELL CULTURE INVOLVING HOMOGENIZATION
#217Influenza virus vaccine composition and methods of use
#218Method of isolation and purification of trypsin from pronase protease and use thereof
#219Materials and methods for respiratory disease control in canines
#220Recombinant influenza vectors with tandem transcription units
#221METHODS FOR ISOLATING ENVELOPED VIRUS-BASED VLPS FREE OF INFECTIOUS AGENTS
#222High growth reassortant influenza A virus
#223DNA transfection system for the generation of negative strand RNA virus
#224NOVEL METHOD
#225Influenza virus immunizing epitope
#226Method for producing purified influenza virus antigen
#227CELL-BASED SYSTEMS FOR PRODUCING INFLUENZA VACCINES
#228RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY
#229FLOW THROUGH PURIFICATION PROCESSES FOR LARGE BIOMOLECULES
#230Antiviral peptide against avian influenza virus H9N2
#231Swine influenza hemagglutinin variants
#232METHOD OF REPLICATING VIRUSES IN SUSPENSION CULTURES OF DOG KIDNEY CELLS
#233Methods of producing an antisense viral particle population
#234CHROMATOGRAPHY MEDIUM
#235Method for concentrating viruses, method for concentrating cells or bacteria, and magnetic composite
#236Influenza Vaccines Containing Hemagglutinin and Matrix Proteins
#237Chromatography medium, preparation method of the same, and method for producing virus vaccine using the chromatography medium
#238RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ
#239Influenza Virus Genome Replication and Transcription System in Yeast Cells
#240Single expression vector for generation of a virus with a segmented genome
#241Influenza composition
#242Formulation of Sugar Solutions for Continuous Ultracentrifugation for Virus Purification
#243Two-Step Temperature Profile for the Propagation of Viruses
#244NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#245Cells for detection and production of influenza and parainfluenza viruses
#246INFLUENZA VIRUS VACCINE COMPOSITION AND METHODS OF USE
#247Oil-in-water emulsion influenza vaccine
#248Adjuvant compositions and methods of use
#249ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#250Method of purifying influenza virus and removing MDCK cell DNA contaminants
#251Non-tumorigenic MDCK cell line for propagating viruses
#252Methods for cultivating cells, propagating and purifying viruses
#253Assay for the separation and quantification of hemagglutinin antigens
#254Cell-based systems for producing influenza vaccines
#255MAKING INFLUENZA VIRUS VACCINES WITHOUT USING EGGS
#256Medium supplement for virus production
#257Production of vaccines
#258Adjuvant compositions
#259Refrigerator-temperature stable influenza vaccine compositions
#260Cell-derived viral vaccines with low levels of residual cell DNA
#261Multi plasmid system for the production of influenza virus
#262NOVEL PROTEOSOME-LIPOSACCHARIDE VACCINE ADJUVANT
#263RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY
#264Methods of Producing Influenza Vaccine Compositions
#265Process for stabilizing an adjuvant containing vaccine composition
#266Method for producing continuous cell lines
#267Multi plasmid system for the production of influenza virus
#268Adjuvant for vaccines
#269Methods for the propagation of modified influenza viruses in embryonated eggs
#270Recombinant protein production in a human cell
#271Influenza vaccine
#272Production of viral vaccines in suspension on avian embryonic derived stem cell lines
#273Vero cell-based influenza virus strains and vaccines
#274Method for producing viral vaccines
#275Method for harvesting biologics from eggs
#276Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#277CHANGING TH1/TH2 BALANCE IN SPLIT INFLUENZA VACCINES WITH ADJUVANTS
#278Genetically engineered swine influenza virus and uses thereof
#279DNA-transfection system for the generation of infectious influenza virus
#280DNA-transfection system for the generation of infectious influenza virus
#281MDCK CELL LINES SUPPORTING VIRAL GROWTH TO HIGH TITERS AND BIOREACTOR PROCESS USING THE SAME
#282Two-step temperature profile for the propagation of viruses
#283Recombinant protein production in a human cell
#284ANIMAL CELLS AND PROCESSES FOR THE REPLICATION OF INFLUENZA VIRUSES
#285Formulation of sugar solutions for continuous ultracentrifugation for virus purification
#286Process for the Production of an Influenza Vaccine
#287DNA-transfection system for the generation of infectious influenza virus
#288Immunstimulating lipid formulation
#289Method for Replicating Influenza Virus in Culture
#290Materials and methods for respiratory disease control in canines
#291Influenza virus vaccine composition and methods of use
#292Production of viruses, viral isolates and vaccines
#293Influenza virus vaccine composition and methods of use
#294Method of isolation and purification of trypsin from pronase protease and use thereof
#295Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus
#296Over-expression of enzymes involved in post-translational protein modifications in human cells
#297High titer recombinant influenza viruses for vaccines
#298Assay for the separation and quantification of hemagglutinin antigens
#299Methods of Producing Influenza Vaccine Compositions
#300Influenza vaccine